Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Short term Debt (2019 - 2025)

Viemed Healthcare's Short term Debt history spans 7 years, with the latest figure at $1.1 million for Q4 2025.

  • For Q4 2025, Short term Debt rose 166.5% year-over-year to $1.1 million; the TTM value through Dec 2025 reached $1.1 million, up 166.5%, while the annual FY2025 figure was $1.1 million, 166.5% up from the prior year.
  • Short term Debt reached $1.1 million in Q4 2025 per VMD's latest filing, down from $1.6 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $3.2 million in Q2 2023 to a low of $165000.0 in Q3 2022.
  • Average Short term Debt over 5 years is $1.2 million, with a median of $1.1 million recorded in 2022.
  • Peak YoY movement for Short term Debt: tumbled 91.34% in 2022, then surged 1011.52% in 2023.
  • A 5-year view of Short term Debt shows it stood at $1.5 million in 2021, then crashed by 88.85% to $165000.0 in 2022, then skyrocketed by 549.7% to $1.1 million in 2023, then crashed by 61.85% to $409000.0 in 2024, then surged by 166.5% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for VMD's Short term Debt are $1.1 million (Q4 2025), $1.6 million (Q3 2025), and $820000.0 (Q2 2025).